Sun Pharmaceutical Industries Inc recalls
Sun Pharmaceutical Industries Inc is named on 26 recalls in Recall Relay's records since November 2023, from FDA (49 recalled products: FDA lists each product as its own recall); the most recent was September 25, 2026.
All 49 recalled products, newest first.
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Tretinoin Cream USPFailed Impurities/Degradation Specifications
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Tretinoin Cream UPSFailed Impurities/Degradation Specifications
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Tretinoin Cream USPFailed Impurities/Degradation Specifications
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Carbamazepine TabletsCGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Perampanel CIII TabletsLabeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Fexofenadine Hydrochloride TabletsFailed Impurities/Degradation Specifications
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Budesonide Inhalation SuspensionPresence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Xyvona (levorphanol tartrate tablets)Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Xyvona (levorphanol tartrate tablets)Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
-
Class Iofficial
Sun Pharmaceutical Industries Inc recalls DOXOrubin Hydrochloride Liposome injectionPresence of Particulate matter: Particulate matter identified as glass.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls FluocinonideFailed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls FluocinonideFailed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls FluocinonideFailed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Diclofenac SodiumFailed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Fluocinolone Acetonide Solution Topical Solution USPFailed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Clindamycin Phosphate USPFailed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Kit for the Preparation of Technetium Tc 99m MertiatideFailed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Spironolactone TabletsPresence of foreign substance: identified as aluminum.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Gabapentin CapsulesCross Contamination
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Gabapentin CapsulesCross Contamination
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Morphine Sulfate Extended-Release TabletsFailed Dissolution Specifications
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Nitrofurantoin CapsulesFailed Dissolution Specifications
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Decitabine for Injection 50mg per vialCGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltered bulk for decitabine for injection.
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Xelpros (latanoprost ophthalmic emulsion) 0.005%Failed Release Testing: Out of specification for particulate matter test.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Amphotericin B Liposome for InjectionOut of specification for assay
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Febuxostat Tablets 40mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Febuxostat Tablets 80mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Mesalamine Extended-Release CapsulesFailed Dissolution Specifications: Out of specification for dissolution.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Fexofenadine Hydrochloride TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Zolpidem Tartrate Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Febuxostat Tablets 40mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Febuxostat Tablets 80 mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Niacin Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Niacin Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lurasidone Hydrochloride Tablets 120mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Cinacalcet Tablets 60mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Mesalamine Delayed-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Zolpidem Tartrate Extended-Release TabletsCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Lurasidone Hydrochloride Tablets 60mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Liothyronine Sodium TabletsFailed Impurities/Degradation Specifications
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls buPROPion Hydrochloride Extended-Release TabletsFailed Dissolution Specifications
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Sun Pharmaceutical Industries Inc or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts